<DOC DOCNO="nw/wsj/23/wsj_2335@2335@wsj@nw@en@on">
<ENAMEX TYPE="PERSON">Alan Seelenfreund</ENAMEX> , <ENAMEX TYPE="DATE">52 years old</ENAMEX> , was named chairman of this processor of prescription claims , succeeding <ENAMEX TYPE="PERSON">Thomas W. Field Jr.</ENAMEX> , <ENAMEX TYPE="DATE">55</ENAMEX> , who resigned <ENAMEX TYPE="DATE">last month</ENAMEX> .
Mr. <ENAMEX TYPE="PERSON">Field</ENAMEX> also had been chairman of <ENAMEX TYPE="ORG">McKesson Corp.</ENAMEX> , resigning that post after a dispute with the board over corporate strategy .
Mr. <ENAMEX TYPE="PERSON">Seelenfreund</ENAMEX> is executive vice president and chief financial officer of <ENAMEX TYPE="ORG">McKesson</ENAMEX> and will continue in those roles .
<ENAMEX TYPE="ORG">PCS</ENAMEX> also named <ENAMEX TYPE="PERSON">Rex R. Malson</ENAMEX> , <ENAMEX TYPE="DATE">57</ENAMEX> , executive vice president at <ENAMEX TYPE="ORG">McKesson</ENAMEX> , as a director , filling the seat vacated by Mr. <ENAMEX TYPE="PERSON">Field</ENAMEX> .
Messrs. <ENAMEX TYPE="PERSON">Malson</ENAMEX> and <ENAMEX TYPE="PERSON">Seelenfreund</ENAMEX> are directors of <ENAMEX TYPE="ORG">McKesson</ENAMEX> , which has an <ENAMEX TYPE="PERCENT">86 %</ENAMEX> stake in <ENAMEX TYPE="ORG">PCS</ENAMEX> .
</DOC>
